[ad_1]
Orthocell confirms record $17 million raising to launch into US
Orthocell has confirmed its biggest ever raising, pulling in $17 million to satisfy growing demand for the stock from institutional investors.
The Perth-based regenerative medicine company said the placement to Australian and international institutions at 60¢ a share, a 13 per cent discount to Wednesday’s close, would fund the launch of its flagship nerve repair product Remplir into the United States.
Premium
Subscribers with digital access can view this article.
Already a subscriber?
Login here.
[ad_2]
Source link
#Orthocell #confirms #record #million #raising #launch